Non-small cell lung cancer-pathology and biology

被引:0
|
作者
Wittersheim, Maike [1 ]
Schallenberg, S. [1 ]
Buettner, R. [1 ]
机构
[1] Uniklin Koln, Inst Pathol, Kerpener Str 62, D-50937 Cologne, Germany
来源
ONKOLOGE | 2018年 / 24卷 / 12期
关键词
Lung cancer; Adenocarcinomas; Histopathology; Immunohistochemistry; Molecular pathology; SQUAMOUS-CELL; MET; ADENOCARCINOMA; MUTATION; ROS1; CARCINOMA; GENE; IMMUNOHISTOCHEMISTRY; CLASSIFICATION; REARRANGEMENT;
D O I
10.1007/s00761-018-0461-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundNon-small cell lung cancer (NSCLC) accounts for ca.75% of malignant epithelial neoplasms of the lungs. In recent years profound insight has been gained regarding the molecular mechanisms of lung carcinogenesis and subsequently new targeted therapies as well as immunotherapies have been developed. These advances have had asignificant impact on routine diagnostics in pathology.ObjectiveThe article aims to give an overview of the most common histological subtypes of NSCLC as well as the morphological, immunohistochemical and molecular characteristics.Material and methodsSelective search of the PubMed database.Results and discussionAdenocarcinomas, squamous cell carcinomas and large cell carcinomas are the most common histological subtypes. With the ancillary methods available in routine pathology even poorly differentiated tumors can be assigned to these entities. The NSCLC show numerous genetic changes of which alterations of EGFR, MET, ALK1 and ROS1 are target structures for personalized therapy.
引用
收藏
页码:958 / 966
页数:9
相关论文
共 50 条
  • [41] Angiogenesis and non-small cell lung cancer
    Cox, G
    Jones, JL
    Walker, RA
    Steward, WP
    O'Byrne, KJ
    LUNG CANCER, 2000, 27 (02) : 81 - 100
  • [42] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [43] SURGERY FOR NON-SMALL CELL LUNG CANCER
    Vrtik, Marosh
    Alam, Naveed Z.
    CANCER FORUM, 2013, 37 (02) : 150 - 153
  • [44] Oligoprogression in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    CANCERS, 2021, 13 (22)
  • [45] Screening for non-small cell lung cancer
    Ashton, RW
    Jett, JR
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 253 - 258
  • [46] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [47] The lymphadenectomy in non-small cell lung cancer
    Chiappetta, Marco
    VIDEO-ASSISTED THORACIC SURGERY, 2022, 7
  • [48] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [49] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [50] Pneumonectomy for non-small cell lung cancer
    Ichiki, Yoshinobu
    Nagashima, Akira
    Chikaishi, Yasuhiro
    Yasuda, Manabu
    SURGERY TODAY, 2012, 42 (09) : 830 - 834